These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 10493338

  • 21. Combining tabular, rule-based, and procedural knowledge in computer-based guidelines for childhood immunization.
    Miller PL, Frawley SJ, Sayward FG, Yasnoff WA, Duncan L, Fleming DW.
    Comput Biomed Res; 1997 Jun; 30(3):211-31. PubMed ID: 9281329
    [Abstract] [Full Text] [Related]

  • 22. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
    Deichmann KA, Ferrera G, Tran C, Thomas S, Eymin C, Baudin M.
    Vaccine; 2015 May 11; 33(20):2379-86. PubMed ID: 25765966
    [Abstract] [Full Text] [Related]

  • 23. Combination vaccine use and vaccination quality in a managed care population.
    Happe LE, Lunacsek OE, Marshall GS, Lewis T, Spencer S.
    Am J Manag Care; 2007 Sep 11; 13(9):506-12. PubMed ID: 17803364
    [Abstract] [Full Text] [Related]

  • 24. Immunization practices in children.
    Gershon AA.
    Hosp Pract (Off Ed); 1990 Sep 15; 25(9):91-4, 97-103, 107. PubMed ID: 2118922
    [Abstract] [Full Text] [Related]

  • 25. Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates.
    Dietz VJ, Stevenson J, Zell ER, Cochi S, Hadler S, Eddins D.
    Arch Pediatr Adolesc Med; 1994 Sep 15; 148(9):943-9. PubMed ID: 8075738
    [Abstract] [Full Text] [Related]

  • 26. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M, Fischmeister G, Grac A, Rendi-Wagner P, Kundi M, Mohsenzadeh-Rabbani A, Moritz K, Fenninger B, Jarisch R, Jasinska J, Holzmann H, Wiedermann U, Kollaritsch H.
    Vaccine; 2011 Jul 18; 29(32):5130-6. PubMed ID: 21624412
    [Abstract] [Full Text] [Related]

  • 27. Factors associated with improved immunization rates for urban minority preschool children.
    Mitchell CK, Franco SM.
    Clin Pediatr (Phila); 1995 Sep 18; 34(9):466-70. PubMed ID: 7586918
    [Abstract] [Full Text] [Related]

  • 28. Minimum time interval adjustment for 4-3-1 immunization rates among two-year-old children.
    Steiner RP, Hughes JA, Richardson TL, Looney SW, Clover RD, Rowe MG.
    Am J Prev Med; 1999 Apr 18; 16(3):189-94. PubMed ID: 10198657
    [Abstract] [Full Text] [Related]

  • 29. [Routine preventive vaccinations].
    Schubiger G, Desgrandchamps D.
    Praxis (Bern 1994); 1998 Jan 28; 87(5):165-7. PubMed ID: 9522635
    [Abstract] [Full Text] [Related]

  • 30. Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants.
    Madhi SA, Koen A, Cutland C, Groome M, Santos-Lima E.
    Pediatr Infect Dis J; 2013 Aug 28; 32(8):889-97. PubMed ID: 23538523
    [Abstract] [Full Text] [Related]

  • 31. Errors and correlates in parental recall of child immunizations: effects on vaccination coverage estimates.
    Suarez L, Simpson DM, Smith DR.
    Pediatrics; 1997 May 28; 99(5):E3. PubMed ID: 9113960
    [Abstract] [Full Text] [Related]

  • 32. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group.
    White CJ, Stinson D, Staehle B, Cho I, Matthews H, Ngai A, Keller P, Eiden J, Kuter B.
    Clin Infect Dis; 1997 May 28; 24(5):925-31. PubMed ID: 9142794
    [Abstract] [Full Text] [Related]

  • 33. Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX.
    Shinefield HR, Black SB, Staehle BO, Adelman T, Ensor K, Ngai A, White CJ, Bird SR, Matthews H, Kuter BJ.
    Pediatr Infect Dis J; 1998 Nov 28; 17(11):980-5. PubMed ID: 9849978
    [Abstract] [Full Text] [Related]

  • 34. Underimmunization of American Indian and Alaska Native children.
    Groom AV, Washington ML, Smith PJ, Bryan RT.
    Pediatrics; 2008 May 28; 121(5):938-44. PubMed ID: 18450897
    [Abstract] [Full Text] [Related]

  • 35. Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association.
    MMWR Recomm Rep; 1996 Nov 22; 45(RR-13):1-16. PubMed ID: 8965784
    [Abstract] [Full Text] [Related]

  • 36. The delivery of immunizations and other preventive services in private practices.
    Bordley WC, Margolis PA, Lannon CM.
    Pediatrics; 1996 Apr 22; 97(4):467-73. PubMed ID: 8632930
    [Abstract] [Full Text] [Related]

  • 37. Impact of a decline in Colorado Medicaid managed care enrollment on access and quality of preventive primary care services.
    Berman S, Armon C, Todd J.
    Pediatrics; 2005 Dec 22; 116(6):1474-9. PubMed ID: 16322173
    [Abstract] [Full Text] [Related]

  • 38. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
    Vesikari T, Joensuu J, Baer M, Käyhty H, Olander RM, Sormunen H, Miettinen A, Ward RL, Guillot T.
    Acta Paediatr; 1999 May 22; 88(5):513-20. PubMed ID: 10426173
    [Abstract] [Full Text] [Related]

  • 39. [Preventive vaccination (DPT, HiB, polio, MMR) in hepatitis B virus carrier status?].
    Wiersbitzky S.
    Kinderarztl Prax; 1993 Dec 22; 61(10):376-7. PubMed ID: 8145455
    [No Abstract] [Full Text] [Related]

  • 40. Timeliness of routine immunization in a population-based Italian cohort of very preterm infants: results of the ACTION follow-up project.
    Tozzi AE, Piga S, Corchia C, Di Lallo D, Carnielli V, Chiandotto V, Fertz MC, Miniaci S, Rusconi F, Cuttini M.
    Vaccine; 2014 Feb 07; 32(7):793-9. PubMed ID: 24397902
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.